Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data.

Diagnostic molecular pathology : the American journal of surgical pathology, part B - 1 Jun 2013

Tabyaoui Imane, Tahiri-Jouti Nadia, Serhier Zineb, El Maani Khadija, Cherkaoui Siham, Al Zemmouri Mounia, Othmani Mohamed B, Zamiati Soumaya

Abstract excerpt

MYCN protooncogene status was assessed for the first time in Morocco in peripheral neuroblastic tumors, including neuroblastoma, ganglioneuroblastoma, and ganglioneuroma. Correlations with age at diagnosis, stage, mitosis-karyorrhexis index, differentiation, and Shimada histology were evaluated....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Amplification
Share to Genetic Loci

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to In Situ Hybridization, Fluorescence

Share to Morocco

Share to N-Myc Proto-Oncogene Protein

Share to Neuroblastoma

Share to Oncogene Proteins

Share to Specimen Handling

Source

Identifiers

PMID: 23628823
DOI: 10.1097/PDM.0b013e318277448e

Genes

MYCN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23628823-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data.PMID 23628823Read ↗

Copy number gain of MYCN gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients.Semantic proximity Read ↗

Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology GroupSemantic proximity Read ↗

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group studySemantic proximity Read ↗

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COGSemantic proximity Read ↗

MYCN protein stability is a better prognostic indicator in neuroblastomaSemantic proximity Read ↗

The neuroblastoma and ganglion components of nodular ganglioneuroblastoma are genetically similar: evidence against separate clonal origins.Semantic proximity Read ↗

Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.Semantic proximity Read ↗

MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastomaSemantic proximity Read ↗

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma StudySemantic proximity Read ↗

Detection of <i>MYCN</i> Amplification in Serum DNA Using Conventional Polymerase Chain ReactionSemantic proximity Read ↗

Prediction of <i>MYCN</i> Amplification in Neuroblastoma Using Serum DNA and Real-Time Quantitative Polymerase Chain ReactionSemantic proximity Read ↗

MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.